Analysis of predictive factors influencing dupilumab continuation rate in adult patients with atopic dermatitis: results from an Italian multicenter study

• Main Authors: Niccolò Gori (Author), Alvise Sernicola (Author), Ersilia Tolino (Author), Maria Mariano (Author), Marco Galluzzo (Author), Gaia Moretta (Author), Rosa Coppola (Author), Andrea D'Alessio (Author), Massimo Sansone (Author), Virginia Maffei (Author), Claudia Paolino (Author), Cristian Ferrao (Author), Lauro Cascia (Author), Paola Addio (Author), Lucia Di Nardo (Author), Andrea Chiricozzi (Author), Ester Del Duca (Author), Antonio Cristaudo (Author), Luca Bianchi (Author), Sabatino Pallotta (Author), Vincenzo Panasiti (Author), Giovanni Pellacani (Author), Concetta Potenza (Author), Ketty Peris (Author)
• Format: Knjiga
• Izdano: Taylor & Francis Group, 2023-12-01T00:00:00Z.
• Teme: article
• Online dostop: Connect to this object online.

Objectives The purpose of this study was to analyze the drug survival rate of dupilumab up to 2 years in a large real-world cohort of adult patients affected by moderate/severe atopic dermatitis (AD), and to investigate the clinical, demographic and predictive factors influencing the patients'...